84 results
Page 2 of 5
8-K
EX-10.3
6yaxujpy
28 Jan 20
Entry into a Material Definitive Agreement
6:11am
8-K
EX-10.1
s3ror2lc4
27 Jan 20
Nanoviricides Closes on $8.625 Million Underwritten Public Offering of Common Stock
5:12pm
8-K
EX-10.3
60pq5vo 4m
19 Dec 19
Entry into a Material Definitive Agreement
4:46pm
8-K
EX-10.1
gy2j mlfcc4sgigjn
19 Dec 19
Entry into a Material Definitive Agreement
4:46pm
8-K
EX-10.2
pmgh467g91 t1l
19 Dec 19
Entry into a Material Definitive Agreement
4:46pm
8-K
EX-10.1
1uv m930k
5 Nov 19
NanoViricides Completes Licensing for VZV Field which Includes Shingles Drug Development
9:39pm
S-1
EX-10.16
19gb8l6 caa
28 Sep 19
IPO registration
3:07am
S-1
EX-10.7
hmuo7yz86 q5bxwusx
28 Sep 19
IPO registration
3:07am
8-K
EX-10.1
2ifep38
10 Jun 19
Departure of Directors or Certain Officers
6:02am
8-K
EX-10.2
7le89 2xcyib90gsul0
1 Mar 19
NanoViricides Announces $2.5 Million Financing in a Registered Direct Offering
6:11am